Kaan Oysul

Kaan Oysul

Auto-generated profile, based on publicly available information

Kaan Oysul

Medicana International Ankara Hospital

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2020 in Turkish Journal of Ophthalmology
Verified
Journal Article
Open access
GÖGökçen Özcan
Gökçen Özcan
AGAhmet Kaan Gündüz
Ahmet Kaan Gündüz
IMIbadulla Mirzayev
Ibadulla Mirzayev
KOKaan Oysul
Kaan Oysul
HUHasan Armağan Uysal
Hasan Armağan Uysal
To report treatment results and complications of stereotactic radiosurgery in uveal malignant melanoma and to identify risk factors for development of radiation retinopathy. This was a retrospective study of 36 patients diagnosed with uveal melanoma between 2014 and 2019. Best corrected visual acuity, funduscopic findings, basal tumor diameter and tumor thickness were recorded at baseline and at follow-up visits at 3-month intervals. The response of tumors to stereotactic radiosurgery and complications were determined. The mean basal diameter of tumor was 10.2 (range: 4.0-19.4, standard deviation [SD]: ±3.3) mm x 9.7 (range: 4.5-18.0, SD: ±3.3), tumor thickness was 5.1 (range: 2.0-11.0, ±2.4) mm at baseline. The mean follow-up period was 17.2 (range: 6-48, SD: ±10.43) months. The mean visual acuity was 0.5 (SD: ±0.3) logMAR before treatment and 0.6 (SD: ±0.3) logMAR after the mean follow-up period. The most common complications after stereotactic radiosurgery were cataract (38.9%) and radiation retinopathy (27.7%). There was a statistically significant relation between radiation retinopathy development and tumor distance from the optic disc (p=0.04). The rate of eye salvage was 83.3% in this study. Our short-term results show stereotactic radiosurgery was an effective and sustained treatment modality among the other eye conservation therapies.

1 January 2002 in Haematologia
Verified
Journal Article
Closed access
PDF file
FAFikret Arpaci
Fikret Arpaci
BDBahar Dirican
Bahar Dirican
MBMurat Beyzadeoglu
Murat Beyzadeoglu
KOKaan Oysul
Kaan Oysul
YPYucel Pak
Yucel Pak
"Evaluation of fractionated total body irradiation and dose rate on cataractogenesis in bone marrow transplantation" published on 01 Jan 2002 by VSP.

29 January 2008 in Tumori Journal
Verified
Journal Article
Closed access
PDF file
SSSerdar Surenkok
Serdar Surenkok
MBMurat Beyzadeoglu
Murat Beyzadeoglu
KOKaan Oysul
Kaan Oysul
GOGokhan Ozyigit
Gokhan Ozyigit
SASelmin Ataergin
Selmin Ataergin
AÖAhmet Özet
Ahmet Özet
Aims and background: We assessed the therapeutic results and tolerability of postoperative chemoradiotherapy with either oral UFT or 5-fluorouracil for carcinoma of the stomach. Methods and study design: Forty-six patients treated with chemoradiotherapy following total or subtotal gastrectomy for gastric carcinoma formed the cohort evaluated. The group included 39 males and 7 females whose ages ranged from 21 to 74 years (median, 53 years). In all patients, surgical therapy was the initial approach with a curative intent. The types of operations performed were total gastrectomy in 11 or subtotal gastrectomy in 35 patients. Radiotherapy began from 14 to 161 days after surgery (median, 55 days). Twenty patients received concomitant oral UFT (200 mg/m2), and 26 patients were given 5-fluorouracil (425 mg/m2, iv bolus) concurrently with irradiation consisting of one or two cycles, usually as a 3-day bolus at the start and last 3 days of irradiation therapy for radiosensitizing purposes. The patients were treated using either cobalt-60 or 6 MV photons, and irradiation doses delivered to the tumor bed and regional lymphatics ranged from 40 to 50 Gy (median, 46 Gy). Results: Median follow-up for the entire group was 24 months (range, 2–67). The 2-year overall survival of the entire group of patients was 64%. The 2-year overall survival rates for 5-fluorouracil and oral UFT groups were 72% and 66%, respectively (P = 0.3). Treatment-related factors were reviewed to identify any impact on survival. Analyses included type of surgery and dissection, fraction size, the total dose of irradiation and the type of chemotherapy. A significant detrimental effect in survival in the patients treated with D2 dissection compared to the patients treated with D1 dissection was noted (P = 0.01). Overall grade II-III toxicity of oral UFT was significantly lower than 5-FU (4 patients vs 14 patients, P = 0.03). Conclusions: Concomitant use of oral UFT with radiation seems to be more tolerable and an equally effective regimen in the treatment of locally advanced gastric cancer compared with 5-fluorouracil. D2 dissection was found to have detrimental effects on survival in this cohort.

1 January 2004 in Acta Chirurgica Belgica
Verified
Journal Article
Closed access
MBM. Balkan
M. Balkan
MBM. Beyzadeoglu
M. Beyzadeoglu
ABA. Balkan
A. Balkan
KOK. Oysul
K. Oysul
MSM. Safali
M. Safali
OKO. Kozak
O. Kozak
The Muir-Torre syndrome is characterized by cutaneous neoplasms and visceral malignancies. At least one sebaceous adenoma, epithelioma or carcinoma and at least one internal malignancy are required to make a reliable diagnosis. According to medical literature only two cases of Muir-Torre syndrome with jejunal carcinoma have been reported to date and there is no reported case with intestinal obstruction. Here, we report an unusual case of jejunal carcinoma presenting with ileus.

30 June 2023 in Cumhuriyet Science Journal
Verified
Journal Article
Open access
PDF file
KSKevser Sözen
Kevser Sözen
HUHasan Armağan Uysal
Hasan Armağan Uysal
NBNihal Büyükçi̇zmeci̇
Nihal Büyükçi̇zmeci̇
KOKaan Oysul
Kaan Oysul
While the use of CyberKnife® radiosurgery systems is increasing, the choice of treatment plan is also important. In this study, it was aimed to determine the more advantageous application by comparing the irradiation of all metastases at once and the protocols of irradiation of metastases separately in multiple brain metastases. For this, on an entirely new head phantom; 6 brain metastases and 3 critical organs, including the spinal cord, brain stem, and chiasm, were determined over the spaces where the dosimeters were placed. Computed tomography (CT) images of the head phantom were taken and these 6 tumors and 3 critical organs were drawn (contouring) on the image. In the treatment planning system, the dose we wanted to give was written and irradiation plans were created to be done separately with a single irradiation. Luminescence (OSL) dosimeters with BeO optical excitation were removed from the phantom after each irradiation and the count value obtained from the dosimeter reader device was recorded. Homogeneity index (HI), conformity index (CI), new conformity index (nCI), duration of treatment, and gradient index (GI) values of irradiation at one time and separately were compared. While it was found that irradiation of tumors with a separate treatment plan was more advantageous in terms of conformity index (CI), new conformity index (nCI), homogeneity index (HI), and coverage values, it was seen that a single plan was more suitable in terms of gradient index and duration.

28 September 2026 in Physics in Medicine & Biology
Verified
Journal Article
Open access
MEMehmet Fazil Enkavi
Mehmet Fazil Enkavi
HUHasan Uysal
Hasan Uysal
KOKaan Oysul
Kaan Oysul
SSSait Sirin
Sait Sirin
HEHulya Yavuz Ersan
Hulya Yavuz Ersan
Objective. To develop a high-spatial-resolution Cherenkov-excited fluorescence dosimetry system (CEFD) with rapid optical readout using quinine sulfate solution and evaluate its feasibility for small-field dosimetry and verification of patient-derived stereotactic radiosurgery (SRS) dose distributions. Approach. A 3D-printed optical phantom containing 1 g l −1 quinine sulfate solution was imaged with a complementary metal-oxide-semiconductor camera through a 45° mirror. Sensitive-volume thicknesses of 2.5, 5, 10 and 15 mm were compared using calibration response, signal-to-noise ratio, output factors, dose-rate dependence, and small-field beam profiles benchmarked against a PTW 60023 microSilicon detector. The selected CEFD configuration was further evaluated for thermal response, repeatability, signal drift, low-MU response, and small-field gamma performance, and then used for fixed-gantry verification of 31 patient-derived SRS dose distributions. GafChromic EBT3 film was used as the high-spatial-resolution comparator. Main results. The CEFD achieved 0.065 mm pixel −1 spatial sampling. CEFD-10 showed the most balanced overall performance across sensitivity, dose-rate response, output-factor agreement, and small-field profile measurements. Dose-rate deviations remained within 1.7% at 300–1400 MU min −1 . Passive heat sinking reduced the coefficient of variation from 0.26%–0.13% and limited signal drift from 4.3%–0.97% over 30 consecutive measurements. For the 0.5 × 0.5 cm 2 field, the CEFD-10 central-axis dose ratio relative to the treatment planning system-projected dose remained within ±2% from 10 MU onward. For 0.5 × 0.5–3 × 3 cm 2 static fields, CEFD-10 achieved 99.56%–100.0% global 2%/1 mm gamma passing rates with a 10% low-dose threshold. For patient-derived SRS verification, CEFD-10 achieved mean global gamma passing rates of 99.47 ± 1.58% and 97.53 ± 3.58% for 2%/2 mm and 2%/1 mm criteria, respectively, with mean differences from EBT3 film of −0.32% and −0.21%, respectively. Significance. This study demonstrates compact, high-spatial-resolution, rapid-readout optical dosimetry for small-field and patient-derived SRS dose patterns. Agreement with EBT3 film supports CEFD-10 as a controlled-geometry SRS dose verification.